Related Experiment Video

Updated: Sep 19, 2025

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

15.3K

Long-term remission with allogeneic transplant in patients with refractory/relapsed cutaneous cytotoxic T-cell

Wen-Kai Weng1,2, Chaitanya Iragavarapu1, Gavin M Weng2

  • 1Blood and Marrow Transplantation & Cellular Therapy Division, Department of Medicine, Stanford University School of Medicine, Stanford, CA.

Blood Neoplasia
|June 2, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

8.0K
In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

14.5K

Related Experiment Videos

Last Updated: Sep 19, 2025

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

15.3K
Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

8.0K
In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

14.5K

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

509
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
509
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

74.3K
Overview
74.3K

Articles linked to this work by shared authors, journal, and citation graph.

Cutaneous Lymphoma International Prognostic Index and Risk Stratification in Advanced Mycosis Fungoides and Sézary Syndrome.

JAMA dermatology·2026

Phase 1 Trial with Soquelitinib, a Selective ITK Inhibitor for Treatment of Relapsed/Refractory T Cell Lymphomas.

Blood·2026

Personalized Circulating Tumor DNA Profiling Enables Superior and Universal Residual Disease Detection in Acute Myeloid Leukemia.

Blood cancer discovery·2026

Primary Cutaneous Gamma-Delta T-Cell Lymphoma Complicating Long-Standing Immunosuppressed Dermatomyositis.

Journal of cutaneous pathology·2026

Dissecting Immune Determinants in Lesional Skin of Cutaneous T-Cell Lymphoma During Mogamulizumab Therapy.

Cancers·2026

Synthesis and characterization of soquelitinib a selective ITK inhibitor that modulates tumor immunity.

npj drug discovery·2026

Racial and socioeconomic differences in time to treatment initiation and outcomes in aggressive non-Hodgkin lymphoma.

Blood neoplasia·2026

Prognostic implications of TET2 variant allele frequency in chronic myelomonocytic leukemia: a multicenter study.

Blood neoplasia·2026

A comparison of overall survival and quality of life in patients with MDS treated with azacytidine vs decitabine.

Blood neoplasia·2026

Real-world outcomes of mosunetuzumab use in relapsed/refractory indolent lymphomas: a CUBIC consortium analysis.

Blood neoplasia·2026

Pitavastatin counteracts venetoclax resistance mechanisms including TP53 mutation in acute myeloid leukemia.

Blood neoplasia·2026

IMiD/CELMoD resistance in myeloma is associated with changes in lipid metabolism that may be targetable.

Blood neoplasia·2026

Checkpoint blockade before allogeneic transplantation in pediatric lymphoma warrants a dedicated safety strategy. Comment on: "Immune checkpoint therapy in pediatric and adolescent lymphomas".

Haematologica·2026

Clinical significance of persistent C4d deposition on sequential protocol biopsies in ABO-incompatible kidney transplantation.

Frontiers in nephrology·2026

Thyroid and Parathyroid Dysfunction Following Larynx-Trachea-Thyroid-Parathyroid Allotransplantation.

The Laryngoscope·2026

Pre-transplant bone marrow lymphocyte subsets predict outcome after allogeneic stem cell transplantation.

Frontiers in immunology·2026

Posttransplant Tubulointerstitial Nephritis in Kidney Recipients: From Bacteria to BK Virus: A 24-Year Single-Center Analysis of Etiology, Timing, and Graft Survival.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us